Kevin Patrick Danahy

Insider Reports History

Entity
Individual
Location
50 Teaberry Lane, Braintree, MA
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Patrick Danahy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PULSE BIOSCIENCES, INC. Chief Commercial Officer Common Stock 36.5K $313K $8.56 Jul 3, 2024 Direct
Pulse Biosciences, Inc. Chief Commercial Officer Stock Option (right to buy) 460K Nov 1, 2023 Direct
PULSE BIOSCIENCES, INC. Chief Commercial Officer Warrant (right to buy) 325 Jul 3, 2024 Direct

Insider Reports Filed by Kevin Patrick Danahy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLSE PULSE BIOSCIENCES, INC. Jul 3, 2024 3 $0 4 Jul 9, 2024 Chief Commercial Officer
PLSE Pulse Biosciences, Inc. Nov 16, 2023 3 $35.2K 4 Nov 17, 2023 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Oct 23, 2023 3 $0 4 Nov 3, 2023 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Jul 12, 2023 1 $0 4 Jul 14, 2023 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Apr 29, 2023 1 $0 4 May 2, 2023 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Sep 30, 2022 1 $15K 4 Oct 3, 2022 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Sep 23, 2022 1 $0 4 Sep 27, 2022 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Mar 17, 2022 1 $0 4 Mar 24, 2023 Chief Executive Officer
PLSE Pulse Biosciences, Inc. Feb 14, 2022 1 $0 4 Mar 22, 2022 Chief Commercial Office
PLSE Pulse Biosciences, Inc. Feb 14, 2022 0 $0 3 Mar 22, 2022 Chief Commercial Officer